Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Genesis Lifestyle Medicine: Serving the Union community and beyond.
Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and somatic traits
has received consultancy and/or lecture fees from companies with an interest in developing and marketing incretin-based therapies for treatment of type 2 diabetes mellitus (Boehringer Ingelheim, Lilly, Merck/MSD and Novo Nordisk)
The conversation around these medications has evolved rapidly, from being prescribed solely for type 2 diabetes, to expanded use for the treatment of obesity, cardiovascular, kidney, and liver disease, as well as arthritis, sleep apnea and even for the treatment of substance abuse disorder
